Broncus Medical, Inc.

Broncus Medical, Inc. is a privately funded healthcare company based in San Jose, CA. The Company’s mission is to deliver innovative navigation, diagnostic and therapeutic technologies designed to improve the lives of patients with lung disease through early detection and treatment. The Company holds an impressive intellectual property portfolio of ~75 patents including those issued, licensed, and pending. With commercial and clinical operations in the US, Europe and Asia, Broncus Medical continues to focus on improved clinical outcomes for patients and healthcare professionals around the world. In 2016, Broncus Medical released Archimedes™ - Total Lung Access Platform. The Archimedes system is an intuitive next generation virtual bronchoscopic navigation system developed with years of experience and clinical feedback from previous generation technology: LungPoint® Virtual Bronchoscopic Navigation System. Archimedes integrates CT, pattern recognition software and fused fluoroscopy to provide real-time airway navigation and Bronchoscopic Trans-Parenchymal Nodule Access (BTPNA) for peripheral lesions that are not within or adjacent to the airway. The Archimedes procedure planning software, also available as a satellite planning laptop for greater versatility, combines state-of-the-art nodule, vessel and airway mapping technology with virtual pathway guidance to ensure a safe and efficient airway or BTPNA procedure. The proprietary software and design allows for the use of existing off the shelf tools during airway navigation and a simple access kit for BTPNA. As a platform, Archimedes provides clinical options never before available for access, diagnosis and treatment of lung disease.